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A B S T R A C T
Porcine parvovirus type 1 (PPV1) and porcine circovirus type 2 (PCV2) are small single-stranded DNA viruses
with high prevalence in the global pig population. The aim of this study was to compare and contrast PCV2 and
PPV1 infections in high-health status pigs and to describe PCV2 long-term infection dynamics. Six caesarian-
derived colostrum-deprived pigs were randomly divided into two groups and were experimentally infected with
PCV2 or PPV1 at 5 weeks of age. All pigs had detectable viremia by day (D) 3 post-infection. Pigs infected with
PPV1 had a detectable INF-α response by D3 followed by a high IFN-γ response by D6. The PPV1 pigs developed
antibodies against PPV1 by D6 resulting in decreasing virus titers until PPV1 DNA became undetectable from
D28 until D42. In contrast, PCV2-infected pigs had no detectable INF-α or IFN-γ response after PCV2 infection.
PCV2-infected pigs had no detectable anti-PCV2 humoral response until D49 and had a sustained high level of
PCV2 DNA for the duration of the study. While PPV1-infected pigs were clinically normal, PCV2-infected pigs
developed severe clinical illness including fatal systemic porcine circovirus associated disease (PCVAD) by D28,
fatal enteric PCVAD by D56 and chronic PCVAD manifested as decreased weight gain and periods of diarrhea.
Microscopically, all three PCV2-infected pigs had lymphoid lesions consistent with PCVAD and associated with
low (chronic disease) to high (acute disease) levels of PCV2 antigen. Under the study conditions, there was a lack
of early IFN-γ and INF-α activation followed by a delayed and low humoral immune response and persisting
viremia with PCV2 infection. In contrast, PPV1-infected pigs had IFN-γ and INF-α activation and an eﬀective
immune response to the PPV1 infection.
1. Introduction
Several small, non-enveloped, single-stranded DNA viruses circulate
in pigs including porcine circovirus type 2 (PCV2) and porcine parvo-
virus type 1 (PPV1). Both of these viruses are highly resistant to in-
activation and widespread in pig herds worldwide. While there are
several parvovirus species (PPV1 (Dunne et al., 1965), PPV2 (Hijikata
et al., 2001), PPV3 (Lau et al., 2008), PPV4 (Cheung et al., 2010), PPV5
(Xiao et al., 2013), PPV6 (Ni et al., 2014), PPV7 (Palinski et al., 2016)),
only PPV1 is typically associated with disease. PPV1 was ﬁrst identiﬁed
in the 1960s as a cause of reproductive failure in breeding herds
(Mengeling et al., 1991) but can also cause cutaneous lesions in
growing pigs (Kresse et al., 1985; Lager and Mengeling, 1994). PPV1
has a tropism for actively replicating cells such as fetal myocardiocytes
and fetal infection often results in death, which, depending on the stage
of pregnancy, can manifest as increased numbers of mummiﬁed fetuses,
stillborn or weak born pigs. Vaccines to control PPV1 are routinely used
in breeding herds.
PCV2 is associated with several diﬀerent clinical presentations of
pigs referred to as PCV2 associated disease or PCVAD. Systemic disease
(Opriessnig et al., 2007) or postweaning multisystemic wasting syn-
drome (Harding, 2007) in growing pigs is the most common PCVAD.
PCV2 also plays a role in the porcine respiratory disease complex
(Harms et al., 2002; Kim et al., 2003) and has been associated with
enteric disease in grow-ﬁnish pigs (Jensen et al., 2006; Opriessnig et al.,
2011a). An association with porcine dermatitis and nephropathy syn-
drome (PDNS) is also suspected (Rosell et al., 1999); however, PDNS
may occur in pigs free of PCV2 indicating that several factors can cause
this disease syndrome. PCV2 strains can be divided into diﬀerent gen-
otypes of which PCV2a was the most prevalent genotype before 2000
(Fenaux et al., 2000), followed by a global shift towards PCV2b
(Patterson and Opriessnig, 2010) which has since been followed by
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another shift towards PCV2d (Xiao et al., 2015). While diﬀerences in
pathogenicity between PCV2 genotypes are suspected, experimental
comparison of strains revealed that strain diﬀerences may be more
important than genotype diﬀerences (Opriessnig et al., 2008;
Opriessnig et al., 2014b). Vaccines to control PCV2 are routinely used
in growing pigs and less frequently in the breeding herd.
The aim of this study was to generate anti-PPV1 and anti-PCV2
antiserum over time from high health status pigs; however, unique in-
fection kinetics were observed and thus are described in this manu-
script.
2. Materials and methods
2.1. Ethical statement
The experimental protocols were approved by the Iowa State
University Institutional Animal Care and Use Committee (Approval
number: 1-11-7071-S).
2.2. Animals, housing, experimental design and serum collection
Six 4-week-old, caesarian-derived colostrum-deprived (CDCD) male
pigs from one litter were obtained from a commercial source (Struve
Labs International, Manning, IA, USA), transported to Iowa State
University, and randomly divided into two groups and rooms of three
pigs. The aim of the study was to generate antibody positive control
serum for PCV2 and PPV1 for future evaluation and standardization of
serology assays. The experimental design is summarized in Fig. 1. The
experimental endpoint of the study was initially day 49 (D49) as anti-
body levels to PPV1 and PCV2 are usually high at that time. To obtain
serum reﬂecting seroconversion with low to medium levels of anti-
bodies, blood was collected initially every three days until D15 then on
D21 and weekly thereafter. Blood was collected in serum separator
tubes (Fisher Scientiﬁc, Pittsburgh, PA, USA), centrifuged at 3000×g
for 10 min at 4 °C and the serum was stored at −80 °C until testing.
2.3. Inoculation
At 5 weeks of age, pigs 121, 124 and 125 in the PCV2 group were
inoculated using an infectious PCV2a stock (strain 40895; Fenaux et al.,
2003) with a titer of 104.5 50% tissue culture infectious dose (TCID50)
per ml intramuscularly (1 ml) and intransally (1 ml). For the PPV1 in-
oculation, a frozen tissue stock inoculum (NADC, Ames, Iowa) was used
as described (Opriessnig et al., 2011b). In brief, PPV isolate NADL-8
was isolated in fetal porcine kidney cells from a naturally infected pig in
1977 (Mengeling, 1979) and was subsequently passaged in fetuses in
the pregnant sow model. Passage 4 of the PPV challenge virus stock was
used at an approximate titer of 104.9 TCID50 per ml (Opriessnig et al.,
2011b). Each pig in the PPV1 group (pigs 99, 122 and 123) received
1 ml of the PPV1 tissue homogenate intranasally by slowly dripping
0.5 ml into each nostril.
2.4. Clinical observations
All animals were examined daily for signs of illness such as lethargy,
respiratory disease, diarrhea, inappetence and lameness.
2.5. Serology
All serum samples were tested for the presence of PCV2 IgG by an in
house indirect ORF2-based ELISA (Nawagitgul et al., 2002). Samples
were considered positive if the sample-to-positive (S/P) ratio was equal
to or greater than 0.2 (Nawagitgul et al., 2002). In addition, all samples
were tested by a commercial blocking whole PCV2-based anti-PCV2 IgG
ELISA (SERELISA® PCV2 Ab Mono Blocking; Zoetis). Sample titers were
calculated based on single dilutions using the calculation sheet supplied
by the manufacturer. To determine the presence of PPV1 antibodies, all
serum samples were tested by a commercial blocking ELISA (Ingezim
PPV Compac; R.11.PPV.K3; Ingenasa, Madrid, Spain). This assay is
based on recombinant VP2 PPV1 protein. Samples with a blocking
percentage> 30% are considered positive, samples< 25% are con-
sidered negative, and samples with a blocking percentage from 25 to
30% are considered indeterminate and could be positive or negative.
Serum samples collected at D21 and D35 were also tested for the pre-
sence of PPV1 antibodies by a hemagglutination inhibition (HI) assay as
described (Mengeling et al., 1988).
2.6. DNA extraction, detection and quantiﬁcation amount of PCV2 and
PPV1
Total nucleic acids were extracted from all serum samples using the
MagMax™ Pathogen RNA Kit (Applied Biosystems, Life Technologies,
Carlsbad, CA, USA) on an automated nucleic acid extraction system
(Thermo Scientiﬁc Kingﬁsher® Flex, Thermo Fisher Scientiﬁc,
Pittsburgh, PA, USA) according to the instructions of the manufacturer.
Negative and positive controls were included in each run. All DNA
extracts were tested for the presence of PCV2 with an ORF1-based real-
time PCR assay as described (Opriessnig et al., 2003). In addition, all
DNA extracts were tested for the presence of PPV1 by a quantitative
PPV1 real-time PCR assay targeting the VP2 region (Opriessnig et al.,
2011b). For both assays, samples were considered negative when no
signal was observed by a cycle-threshold (CT) of 40. To further char-
acterize the PCV2 strain present in the pigs, selected PCV2 DNA positive
serum samples were tested by a PCV2a/2b/2d diﬀerential real-time
PCR assay targeting the ORF2 (Opriessnig et al., 2010a; Opriessnig
et al., 2014a). Selected PCV2 DNA positive samples were also subjected
Fig. 1. Experimental design. Blood samples were
collected on certain days indicated by grey circles.
The age of the pigs in weeks is indicated on top.
N = necropsy.
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to sequencing of ORF2 (Gerber et al., 2013).
2.7. Cytokine analysis via multiplex ﬂuorescent microsphere immunoassay
(FMIA)
Serum samples collected on D0, D3, D6, D9, D12, D15 and D21 were
analyzed for IL1-β, IL-8, IFN-α, IL-10, and INF-γ by a 5-plex FMIA
(Ladinig et al., 2014; Lawson et al., 2010). Due to reagent availability,
the IL-8 standard was replaced by the swine IL-8 recombinant protein
(Cat. N. RP0109S-025, KingFisher, Saint Paul, MN, US). All other
standards, capture and detection antibodies were as described (Ladinig
et al., 2014) and INF-γ was coupled to magnetic beads as described
elsewhere (Lawson et al., 2010). Cytokine standards were diluted with
phosphate buﬀered saline (PBS, pH 7.4). Serum samples were tested at
a 1:3 dilution in PBS supplemented with 1% bovine serum albumin
(BSA) and 0.05% proclin (PBS-B). TNFα levels were estimated using the
MILLIPLEX MAP porcine cytokine/chemokine magnetic bead panel
(Millipore, Merck KGaA, Darmstadt, Germany) according to the man-
ufacturer’s protocol. Coupled microspheres were tested on a MagPix
system (Biorad, Austin, Texas, USA) and results were analyzed with the
Bio-Plex Manager software version 6.1 (Biorad). All mean ﬂuorescence
intensity (MFI) measurements were corrected for their background by
subtracting the MFI of the blank control (beads incubated without
serum samples) from the MFI for the relevant analyte in each sample.
2.8. Necropsy
Pigs were euthanized when developing clinical disease or on D49
whichever came ﬁrst (Fig. 1). By D49 the two remaining PCV2 pigs had
a delayed antibody response and therefore they were kept longer to
allow for seroconversion. Euthanasia was done by intravenous pento-
barbital sodium overdose (Fatal Plus®, Vortech Pharmaceuticals, LTD,
Dearborn, MI, USA). Gross lesions were assessed and recorded. Sections
of the mediastinal, mesenteric, superﬁcial inguinal, external iliac and
tracheobronchial lymph nodes, liver, kidney, spleen, tonsil and lungs
were collected during necropsy and ﬁxed in 10% neutral-buﬀered for-
malin and routinely processed for histopathology.
2.9. Histopathology and immunohistochemistry
Microscopic lesions in PCV2 pigs were evaluated by a veterinary
pathologist blinded to the treatment groups. Lung tissue sections were
scored for the presence and severity of interstitial pneumonia, with
scores ranging from 0 (normal) to 6 (severe diﬀuse) (Halbur et al.,
1995). Lymphoid tissues were evaluated for lymphoid depletion and
histiocytic replacement of follicles with scores ranging from 0 (none) to
3 (severe) (Opriessnig et al., 2004). Other tissues were evaluated for
presence of inﬂammation ranging from 0 (none) to 3 (severe). Detec-
tion of PCV2 antigen was performed by PCV2 IHC using a rabbit
polyclonal antiserum (Sorden et al., 1999). The amount of PCV2 an-
tigen was scored by a pathologist blinded to treatment status. Scores
ranged from 0 (no signal) to 3 (abundant, diﬀuse staining).
2.10. Bacteriology
Selected tissues and serum samples were submitted to the Iowa
State University Veterinary Diagnostic Laboratory for bacterial isola-
tion. Erysipelothrix rhusiopathiae IHC was done on selected slides as
described (Opriessnig et al., 2010b).
2.11. Statistical analysis
For cytokine data analysis, JMP® software version 11.0.0 (SAS
Institute, Cary, NC, USA) was used. Summary statistics were calculated
for both groups to assess the overall quality of the data set including
normality. Statistical analysis of the data was performed by using t-
tests. A P-value of less than 0.05 was set as the statistically signiﬁcant
level.
3. Results
3.1. Clinical observations
Clinical signs of disease were not observed in any of the PPV1-in-
fected pigs through the time of scheduled necropsy at D42. All PCV2-
infected pigs were clinically unremarkable until D28 when pig 124 was
found in the morning with severe labored respiration with open-mouth
breathing and cyanosis. Two hours later the pig was recumbent with a
rectal temperature of 39.4 °C and was euthanized. By D49, pig 125
developed pasty-to-liquid diarrhea and by D50 pig 121 developed si-
milar diarrhea and both pigs showed mild respiratory distress. Both pigs
were treated with ceftiofur crystalline free acid (Excede® Zoetis) in-
tramuscularly and enroﬂoxacin (Baytril 100, Bayer Animal Health)
subcutaneously. Pig 121 had mild respiratory distress on D51. Over the
following days, both pigs had rectal temperatures of approximately
38 °C. On D56, pig 121 was found in sternal recumbency with rapid
breathing, cyanosis and abdominal distention and was subsequently
euthanized. Between D64 to D67, pig 125 again developed ﬂuid green-
to-yellow diarrhea often containing undigested feed and was treated
with ceftiofur crystalline free acid and enroﬂoxacin. Pig 125 was eu-
thanized on D117 when the pig was 24 weeks old. At that time the pig
was active and alert.
3.2. Anti-PCV2 and anti-PPV1 antibody levels
All PPV1 pigs were negative for anti-PCV2 and anti-PPV1 antibodies
at arrival and all pigs remained negative for PCV2 antibodies. Anti-
PPV1 IgG antibodies were ﬁrst detected in all three PPV1 pigs at D6
(blocking percentage 31.3-42). PPV1 antibody levels continued to in-
crease and reached approximately 100% by D15. The PPV1 antibody
titers remained at that level until termination of the study at D49
(Fig. 2A). All three PPV1 pigs had HI titers of 16384 at D21 and D35.
All PCV2 pigs were negative for anti-PCV2 and anti-PPV1 antibodies
at arrival and remained negative for PPV1 antibodies. Anti-PCV2 IgG
antibodies were ﬁrst detected at D49 in pig 125 by the in-house indirect
ELISA (S/P ratio 0.43) and this pig remained positive at approximately
the same antibody level until termination of the study at D117 (S/P
ratio of 0.59) (Fig. 2B). The same pig was identiﬁed as positive for PCV2
antibodies by the commercial blocking ELISA at D56 (antibody titer of
677) with a similar trend for antibody levels until D117 (antibody titer
550). PCV2 antibodies were not detected in pigs 121 or 124.
3.3. Prevalence and amount of PCV2 and PPV1 DNA in serum samples
All PPV1 pigs were negative for PCV2 and PPV1 DNA in serum
samples at arrival and the pigs remained negative for PCV2 DNA. PPV1
DNA was ﬁrst detected on D3 in all three PPV1 pigs (Fig. 3) and all
remained viremic until D28. PPV1 DNA was detected sporadically at
low levels on D28, D35 and D42 and all three pigs were negative for
PPV1 DNA in serum on D48 (Fig. 3).
Similarly, all PCV2 pigs were negative for PCV2 and PPV1 DNA in
serum samples at arrival and the pigs remained negative for PPV1 DNA.
PCV2 DNA was ﬁrst detected on D3 in all three PCV2 pigs (Fig. 3).
PCV2 pigs developed increasing PCV2 levels in serum approaching le-
vels in the 10 log range by D14 with no decrease in PCV2 levels in pigs
121 and 124 until death. Pig 125, which had similarly high PCV2 levels
compared to the other two pigs, started to have slightly decreased levels
around D49 (9 logs), D56 (8 logs) and it ﬁnally reached 7 logs by D79
and remained at this level until D117 when it was euthanized (Fig. 3).
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3.4. Cytokine responses
The IFN-α, IL-8, IL-1β and IFNγ cytokine responses are summarized
in Fig. 4. In contrast to the PCV2 pigs, all three PPV1 pigs had a high
INF-α response by D3 followed by a high IFN-γ response by D6. For
TNFα, only one of the PPV1 infected pigs showed an increase in the
TNFα levels at D6, whereas all the PCV2 infected pigs had elevated
TNFα levels from D15 onwards (data not shown).
3.5. Gross lesions
The PPV1 pigs were necropsied at D42 when they were 11 weeks
old. Pig 99 had a cystic left kidney, pig 122 had an inﬂamed bursal sac
on the elbow joint and pig 123 had an inﬂamed bursal sac on the knee
joint. There were no other remarkable macroscopic lesions in these
pigs. All lymph nodes were of normal size and age appropriate. Among
the PCV2 pigs, pig 124 (D28) had severe pulmonary edema, severe
diﬀuse mottled tan-purple interstitial pneumonia, 30% cranioventral
purple consolidation of the lung (Fig. 5A) and moderately enlarged
lymph nodes. Pig 121 (D56) had approximately 1 l yellow ﬂuid in the
abdominal cavity and 1 l in the thoracic cavity and pericardium. Lungs
were consolidated and tan to purple in color with moderate ﬁbrinous
pleuritis and tracheobronchial and mediastinal lymph nodes were
markedly enlarged. There were multifocal 1–3 cm, round to rhomboid,
red and slightly raised skin lesions most evident on the back and
perineum (Fig. 5B). Pig 125 (D117) had diﬀuse severe enlargement of
tracheobronchial, renal, hepatic, mesenteric and gastric lymph nodes.
Kidneys were tan, moderately enlarged with multifocal white areas of
ﬁbrosis (Fig. 5C). The liver had moderate to severe interstitial and
lobular ﬁbrosis (Fig. 5D). There were no remarkable lesions in lungs,
small intestines and large intestines.
3.6. Microscopic lesions and PCV2 antigen in tissues
Microscopic lesions and PCV2 antigen levels are summarized in
Table 1 and Fig. 6. Pig 124 (D28) had severe lymphoid depletion of
lymph nodes and Peyer’s patches with vasculitis (Fig. 6K). In lung
sections, there was severe diﬀuse interstitial pneumonia with necro-
tizing and ulcerative bronchiolitis and interstitial and alveolar edema.
In sections of liver there was moderate lymphohistiocytic hepatitis. In
addition, there was severe granulomatous interstitial nephritis
(Fig. 6D). Overall, the lesions in this pig were consistent with systemic
PCVAD. Pig 121 (D56) had severe lymphoid depletion with histiocytic
replacement of follicles, necrosis and hemorrhage in the lung with mild
pulmonary edema, moderate lymphohistiocytic interstitial nephritis
(Fig. 6E, H) and severe granulomatous enteritis associated with abun-
dant PCV2 antigen (Fig. 6K). Due to the history of diarrhea and large
amounts of PCV2 antigen in enteric sections, this pig was diagnosed
with enteric PCVAD following systemic PCVAD. Pig 125 (D117) had
mild lymphoid depletion and histiocytic replacement of lymphoid fol-
licles (Fig. 6L, O), severe interstitial nephritis (Fig. 6F, I) and lympho-
histiocytic myocarditis (Fig. 6D) and was diagnosed with chronic sys-
temic PCVAD.
3.7. Bacteriology
There was no signiﬁcant growth from lungs, spleen and serum from
pigs 121 and 124 which was expected as both pigs had been treated
with antimicrobials. Erysipelothrix rhusiopathiae IHC stains were nega-
tive.
4. Discussion
This report describes the clinical ﬁndings and PCV2 kinetics in three
high health pigs infected with a PCV2a strain and compares and con-
trasts the ﬁndings with age-matched pigs from the same litter infected
with PPV1. All three PCV2 pigs had a high and persistent PCV2 viremia
without detectable PCV2 antibody response other than a weak reaction
in one of the pigs after D49. In contrast, PPV1-infected pigs similarly
became PPV1 viremic after infection and mounted a rapid and high
immune response, which was correlated with virus clearance in these
pigs by D42 after infection. All three PCV2 pigs developed clinical
Fig. 2. Serological response to PPV1 (A) and PCV2 (B) over time using two commercial blocking ELISAs in pigs infected with PPV1 (99, 122 and 123) or PCV2 (121, 124 and 125) at D0.
The red dashed line indicates the ELISA cut-oﬀ. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Fig. 3. Log10 PCV2 genomic copies or PPV1 genomic copies per ml serum in pigs over
time infected with PPV1 (99, 122 and 123) or PCV2 (121, 124 and 125) at D0.
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disease at diﬀerent times after inoculation and the disease course in two
of the three pigs progressed to the point where euthanasia was required.
The lesions in the PCV2 pigs were consistent with PCVAD lesions. No
other agents were detected in any of the pigs, lesions characteristic of
bacterial septicemia were not seen, and all pigs were only infected with
the pathogen they were inoculated with (i.e. PCV2a or PPV1). Other
factors that could have contributed to the development of PCVAD with
PCV2a infection alone as described in this study could include a genetic
predisposition of these pigs (all were from the same litter) and or a
higher susceptibility of CDCD pigs to infectious diseases in general.
It is well recognized that PCV2 infection can persist and that PCV2
DNA can be detected over extended periods of time in serum samples.
Previously, conventionally raised (not CDCD) pigs remained PCV2
viremic for at least 140 days after PCV2 infection (Opriessnig et al.,
2010a). In that study, IgM and IgG antibodies against PCV2 appeared
between 14 and 21 days after infection and viral titers in serum de-
creased by several logs over the following weeks reaching 3–4 logs by
D70. Some immunological diﬀerences can be attributed to diﬀerence
between CDCD pigs versus conventional pigs. However, in other studies
also using CDCD pigs, seroconversion to PCV2 was observed by D21 in
some pigs (Opriessnig et al., 2014a, 2014b). In most experimental
studies published in the literature, PCV2-infected pigs are euthanized at
the anticipated peak of disease between D21 and D35 and data beyond
that time are rare. In the present study, none of the pigs developed
antibodies prior to D49 and the viral titers remained at 10 logs until
D49, decreasing to 8 logs over the following weeks. Treatment with
antimicrobials could also aﬀect host response and the frequent anti-
microbial treatment of the PCV2 pigs could have impacted their im-
mune response.
Lymphoid lesions were severe in pig 124 (D28; abundant PCV2
antigen) and in pig 121 (D56; low-to-moderate amounts of PCV2 an-
tigen) while lymphoid lesions were essentially resolved in pig 124
(D117) (Fig. 6M–O). Previous studies using experimental PCV2 infec-
tion have found that PCV2 associated lymphoid lesions are most severe
between D14 and D21 and usually resolve by D35 (Hoogland et al.,
2006; Opriessnig et al., 2006a). The presence of severe lymphoid de-
pletion at D56 is unusual and likely reﬂected by the uncontrolled per-
sisting PCV2 infection.
Enteric PCVAD is an important diﬀerential diagnosis for granulo-
matous enteritis in pigs. In this study pigs 124 (D28) and 121 (D56)
developed lymphohistiocytic enteritis associated with large amounts of
PCV2 antigen in pig 121 (Fig. 6K). Shortly before euthanasia, this pig
developed red raised skin lesions clinically indistinguishable from
PDNS or acute bacterial septicemia. It is possible that the pig was im-
munocompromised and the integrity of its gut mucosal barrier was lost
leading to secondary bacterial infection and acute septicemia.
Lymphohistiocytic interstitial nephritis is commonly seen with
PCV2 infection (Opriessnig and Langohr, 2013). It has been suggested
that renal lesions indicate chronicity of PCV2 infection with increasing
prevalence after D35. However, because in previous studies these le-
sions were absent in experimental pigs by D69 and D140, eventual
resolution of these lesions has been suggested (Opriessnig and Langohr,
2013). In this study, moderate-to-severe renal lesions (Fig. 6G–I) were
present in all three PCV2 pigs and amount of PCV2 antigen in these
lesions increased with time (Fig. 6D–F) and was highest in pig 125
(D117). Pig 125 had very mild lymphoid lesions highlighting that as-
sessment of several organ systems may be needed to determine disease
causality.
It is well recognized that PCV2 replicates in endothelial cells
(Steiner et al., 2008) and is frequently associated with cardiovascular
lesions in experimentally infected pigs (Opriessnig et al., 2006b) but
also in ﬁeld cases (Resendes and Segalés, 2015). Cardiovascular lesions
were seen in all pigs and associated with the severe interlobular pul-
monary edema and severe diﬀuse segmental to circumferential lym-
phohistiocytic and plasmacytic periarteritis and endarteritis in several
organs in pigs 124 (D28) and 121 (D56) in this study. Diﬀuse distention
of the pulmonary interlobular septa by edema and ﬁbrinoid necrosis of
the blood vessel wall has been described when PCV2b ﬁrst entered the
North American pig population and was attributed to diﬀerences be-
tween PCV2 strains (Carman et al., 2008). In this study, two of three
Fig. 4. Mean group cytokine responses including INF-α, IL-8, IL-1, and INF-γ in ng/mL serum measured at the day of inoculation (D0) and again at D3, D6, D9, D12, D15 and D21 in pigs
infected with PPV1 (white bars) or PCV2 (black bars). Diﬀerent superscripts (A,B) at a trial day indicate signiﬁcant (P<0.05) diﬀerent group means.
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PCV2a infected pigs developed severe interlobular pulmonary edema.
In fetuses, PCV2 replicates in myocardiocytes (Sanchez Jr et al., 2004)
and the myocarditis is often associated with inﬁltration by lympho-
cytes, plasma cells, and macrophages of varying degrees (Opriessnig
et al., 2006b). Severe chronic myocardial lesions were only present in
pig 125 (D117) at 24 weeks of age but not in pigs 124 (D28) or 121
(D56) (Fig. 6A–C). This ﬁnding is unusual as pigs with PCV2 associated
myocarditis are typically much younger and often the lesions are a
result of a previous chronic intrauterine PCV2 infection (Mikami et al.,
2005).
As the PPV1 pigs seroconverted early, the immune system in these
pigs appeared intact and capable of mounting an immune response.
PPV1 pigs had a signiﬁcantly higher IFN-α response by D3 compared to
PCV2 pigs. IFN-α is usually produced by virus infected host cells and
provides resistance to viral replication while increasing MHC-I expres-
sion and antigen presentation and activating NK cells. It is thought that
IFN-γ secreting cells develop during the adaptive response to PCV2 and
probably contribute to viral clearance in infected pigs (Fort et al.,
2009). In this study INF-γ, while present in PPV1 pigs in high levels at
D6, was not detected in the PCV2 pigs. This could explain the high
PCV2 virus loads in these pigs over the course of the study.
Both IL-8 and IL-1 β are secreted by activated macrophages. IL-8
induces a local inﬂammatory response including increased angiogenesis
and IL-1 β activates lymphocytes and induces local tissue destruction.
PCV2 has the ability to induce strong IL-1β and IL-8 responses in per-
ipheral blood mononuclear cells (PBMCs) of both naïve and PCV2-
Fig. 5. Macroscopic lesions in the PCV2 infected pigs. A. Lung, pig 124, D28. There is multifocal severe dark-purple consolidation and moderate interlobular edema. B. Pig 121, D56. The
pig is recumbent and there are multifocal 1–3 cm, round to rhomboid, red and slightly raised skin lesions on the back. C. Kidneys, pig 125, D117. There are multifocal small foci of ﬁbrosis
(arrows). D. Liver, hepatic and gastric lymph nodes. The liver surface has multifocal areas of ﬁbrosis and the liver edges are rounded (bold arrows). Lymph nodes (normal arrows) are
markedly enlarged. (For interpretation of the references to colour in this ﬁgure legend, the reader is referred to the web version of this article.)
Table 1
Microscopic lesions in pigs infected with PCV2 28, 56 or 117 days previously and presence and amount PCV2 antigen associated with the lesions as determined by immunohistochemistry.
Data presented as severity score ranging from 0 = normal; 1 = mild; 2 = moderate to 3 = severe (IHC score ranging from negative (−) to abundant (+++)).
Lymph nodes Lung Liver Kidney Heart Ileum
LD and HR of
follicles
Interlobular edema Peri-bronchiolar
ﬁbrosis
LH hepatitis LH-G interstitial and tubular
nephritis
LH myocarditis LD of Peyer’s
patches
LH enteritis
Pig 124 (D28) 3 (+++) 3 (++) 2 (+++) 1 (++) 3 (++) 0 (0) 3 (+++) 1 (+)
Pig 121 (D56) 3 (+/++) NEC 2 (++) 2 (+) NEC 1 (++) 2 (+++) 0 (0) 1 (+++) 3 (+++)
Pig 125 (D117) 1 (-/+)a 1 (−) 0 (−) 1 (−) 3 (+++) 3 (+) 0 (−) 0 (−)
Abbreviations used: LH = lymphohistiocytic; NEC =multifocal necrosis; G = granulomatous; HR = histiocytic replacement; LD = lymphoid depletion.
a Spleen: focal severe histiocytic replacement of follicles.
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Fig. 6. Microscopic lesions in the PCV2 infected pigs at D28 (top row), D56 (middle row) or D117 (bottom row) post infection. A-C. Heart, HE. A, B: Normal. C: Moderate diﬀuse
lymphohistiocytic myocarditis. D-F. Kidney, HE. Mild-to-moderate, multifocal lymphohistiocytic tubulointerstitial nephritis. G-I. Kidney, PCV2 IHC. Moderate to high amount of PCV2
antigen associated with areas of inﬂammation and renal tubular necrosis. J-L: Ileum, PCV2 IHC. There is no (L), low (J) to high (K) amounts of PCV2 antigen present in the lamina propria
and submucosa of the intestinal sections. M-O. Tonsil, PCV2 IHC. M: Moderate lymphoid depletion associated with large amounts of PCV2 antigen. N: Severe lymphoid depletion with
only a few cells staining positive for PCV2 antigen. O: Normal tonsil negative for PCV2 antigen.
T. Opriessnig et al. Veterinary Immunology and Immunopathology 191 (2017) 51–59
57
infected pigs (Darwich et al., 2003). In this study, an IL-8 response was
seen in PCV2 pigs from D9 through D21 but not in PPV1 pigs. PPV1 or
PCV2 infected pigs had spikes of IL-1β starting at D9 which is typical of
chronic inﬂammation as commonly seen in PCVAD.
TNFα is a pro-inﬂammatory cytokine associated with infections, and
is known to promote loss of epithelial barrier integrity, edema and
cachexia (Capaldo and Nusrat, 2009; Mullin and Snock, 1990). In this
study only pig 99 in the PPV2 infected group showed a transient in-
crease in TNFα levels on D6 through D9 while TNFα was not detected
in any of the other PPV1 pigs. All PCV2 infected pigs; however, con-
sistently showed elevated levels of TNFα starting at D15 which re-
mained elevated. The association between elevated TNFα levels in
PCV2 infected pigs and progressive weight loss has been documented
earlier (Kim et al., 2006; Kreikemeier et al., 2015). Interestingly, in this
study, where other infections have been ruled out, PCV2 alone was
suﬃcient to increase the systemic TNFα levels. This observation may
warrant further analysis of TNFα as a marker in diagnosis of PCVAD.
5. Conclusions
The diﬀerences in responses of CDCD pigs to two common single-
stranded DNA viruses, PCV2 and PPV1, were compared and contrasted.
Under the study conditions, clinical signs and lesions consistent with
PCVAD were reproduced in pigs infected with a PCV2a isolate from
2000. This study highlights the unique immune response to PCV2 in
some pigs and clearly shows that PCV2 can induce systemic cytokine
changes, even in the absence of other known pathogens. This patho-
genesis could be exacerbated by concurrent infection with other pa-
thogens. This study reiterates the importance of controlling PCV2 in-
fection in commercial pig herds.
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